选项

处方审核助手

{:__('collect %s',处方审核助手)}

基于临床指南自动审核处方,识别潜在药物相互作用与剂量风险,生成标准化审核报告。

提示内容 复制 复制

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all prescribed drug names and dosages. Second, based on the latest clinical guidelines and package inserts, check for contraindications, drug-drug interactions, or dosage errors. Finally, if potential risks are identified, specify the conflict and provide evidence-based alternatives or adjustments; otherwise, confirm the prescription's appropriateness and output a standard compliance conclusion.

复制 复制

请作为资深临床药师,对提供的患者处方进行合规性审查。首先,提取患者基本信息、诊断结果及所有拟用药物名称与剂量。其次,依据最新临床用药指南和药品说明书,逐一核查是否存在禁忌症、药物相互作用或超剂量使用风险。最后,若发现潜在风险,请明确指出具体冲突点并提供基于循证医学的替代方案或调整建议;若处方合规,请确认其合理性并输出标准化的审核通过结论。

复制 复制
评论 (0)
0/300

推荐

处方审核助手
Act as a clinical pharmacist and review the provided physician's prescription against the patient's electronic health records, including medical history, allergies, current medications, and lab results. Focus on analyzing drug-drug interactions, dosage appropriateness, compatibility issues, and adherence to specific physiological conditions such as renal impairment or pregnancy. Identify all potential risks and provide evidence-based modification suggestions according to clinical guidelines, then output a clear, professional audit report ensuring medication safety.
处方审核助手
Act as a senior clinical pharmacist to conduct a deep compliance review of the provided patient prescription. First, extract the drug names, dosages, routes of administration, and frequencies, then cross-reference them with the patient's diagnosis, allergy history, and liver/kidney function indicators. Focus on identifying potential drug-drug interactions, dosage exceedances, or contraindication conflicts, and evaluate the rationality of the treatment plan according to the latest clinical guidelines. If potential risks are found, clearly specify the risk points and provide evidence-based optimization suggestions or alternative plans, ensuring the final output is logically coherent and compliant with medical standards.
处方审核助手
Act as a senior clinical pharmacist and review the following prescription for compliance: The patient is a 65-year-old male with a history of chronic kidney disease (creatinine clearance 45ml/min) and hypertension. The current prescription includes Amoxicillin, Amlodipine, and Ibuprofen. Focus on analyzing drug-drug interactions, the necessity for dosage adjustments, and potential nephrotoxicity risks, providing recommendations aligned with clinical guidelines.
处方审核助手
Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, contraindication conflicts, and whether the dosage aligns with the patient's age and hepatic/renal function. Provide adjustment suggestions or risk warnings based on the latest clinical guidelines to ensure the safety and efficacy of the medication regimen.
处方审核助手
Act as a senior clinical pharmacist to evaluate the patient's basic information, medical history, and the proposed medication list. Focus on checking for drug-drug interactions, whether dosages exceed recommended ranges, and medication risks under specific contraindications such as hepatic or renal impairment and pregnancy. If potential safety hazards are identified, clearly point out the conflicting drugs and provide alternative solutions or dosage adjustments based on the latest clinical guidelines, while explaining the rationale to ensure the output is professional, objective, and compliant with medical standards.
处方审核助手
Act as a senior clinical pharmacist to review the provided electronic prescription data for compliance. Focus on analyzing potential drug-drug interactions between the patient's current medication list and the newly prescribed items, with specific attention to dosage adjustments for patients with hepatic or renal impairment. Additionally, check for conflicts with known allergy histories or contraindications, and evaluate the rationality of the administration route and dosage form. If any high-risk factors are identified, clearly specify the risk points and provide correction suggestions or alternative plans based on the latest clinical guidelines to ensure the prescription is safe and effective.
OR